No Data
No Data
The treasure in the high stock price market: 8 stocks with good value and growth potential.
Jefferies Financial strategist screened out 8 "reasonably priced growth" stocks, allowing investors to enjoy strong profit growth while avoiding the risk of high valuations.
Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $27
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $24 to $27.
Oscar Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/12/2024 31.07% Wells Fargo $24 → $27 Maintains Overweight 05/30/2024 1.94% B of A Securities $25 → $21
Tiziana Life Sciences Receives FDA Acceptance For Fast Track Designation Submission Of Intranasal Foralumab For Treating Non-Active Secondary-Progressive Multiple Sclerosis (Na-SPMS)
Tiziana Life Sciences Receives FDA Acceptance For Fast Track Designation Submission Of Intranasal Foralumab For Treating Non-Active Secondary-Progressive Multiple Sclerosis (Na-SPMS)
Progressive Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/10/2024 19.98% Morgan Stanley $256 → $255 Maintains Overweight 05/20/2024 14.34% Wells Fargo $244 → $24
Chubb Unusual Options Activity
Deep-pocketed investors have adopted a bullish approach towards Chubb (NYSE:CB), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this si